Globus Medical, Inc. (NYSE:GMED) Q1 2018 Earnings Conference Call Transcript
May 02, 2018 • 04:30 pm ET
Daniel T. Scavilla
and non-GAAP diluted earnings per share were $0.41. Emerging Technologies negatively impacted Q1 '18 EPS, by approximately $0.01, compared to approximately negative $0.04 in Q1 '17. Adjusted EBITDA for Q1 '18 was 35.4%, reflecting gains from the strong robotics sales, partially offset by increased investments in Emerging Technologies and Spine. Our full year 2018 EBITDA margin, is projected to be in the mid-30s.
We ended the quarter with $473.6 million of cash, cash equivalents and marketable securities. Net cash provided by operating activities in Q1 was $52.3 million, and free cash flow was $39.9 million. The company remains debt-free. The company is increasing guidance for full year 2018 sales by $5 million, to approximately $695 million and increasing non-GAAP diluted earnings per share by $0.02 to $1.52.
We will now open the call for questions.